Li-Li Long

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy

Xue Bai, Ze-Qin Guo, Yan-Pei Zhang et al. · Nature Communications · 2023 · 61 citations · Full text

Life Sciences, Immunology, Oncology +17

Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies

Si-Cong Ma, Xin-Ran Tang, Li-Li Long et al. · OncoImmunology · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16

Oral hairy leukoplakia in an HIV-negative renal transplant patient

R I Macleod, Li-Li Long, J.V. Soames et al. · BDJ · 1990 · 35 citations

Medicine, Dermatology, Immunology +14

PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer

Li-Li Long, Si-Cong Ma, Ze-Qin Guo et al. · Cancer Research · 2022 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation

Xue‐Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong et al. · BMC Medicine · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacology +16